Affiliations 

  • 1 University Clinic for HPV-related gynecological disease, Department of Obstetrics and Gynecology, Gødstrup Hospital, Herning, Denmark; NIDO - Center for research and education, Gødstrup Hospital, Herning, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • 2 School of Public Health, Université de Montréal, Montreal, QC, Canada
  • 3 Reproductive & Neonatal Infectious Diseases, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia; Centre for Women's Infectious Diseases Research, Royal Women's Hospital, Infection and Immunity, Murdoch Children's Research, Melbourne, Australia
  • 4 Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
  • 5 Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK
  • 6 Boston Medical Center/Boston University Chobanian and Avedesian School of Medicine, Boston, MA
  • 7 Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India
  • 8 Department of Population Health Sciences, Duke University School of Medicine, Durham, NC; Department of Mathematics, Duke University, Durham, NC
  • 9 Division of Global Health, National Cancer Institute, Bethesda, MD
  • 10 University Clinic for HPV-related gynecological disease, Department of Obstetrics and Gynecology, Gødstrup Hospital, Herning, Denmark; NIDO - Center for research and education, Gødstrup Hospital, Herning, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: ahlauridsen@clin.au.dk
Am J Obstet Gynecol, 2025 Feb 19.
PMID: 39983886 DOI: 10.1016/j.ajog.2025.02.029

Abstract

Recently, the International Papillomavirus Society convened a working group on cervical human papillomavirus latency, which resulted in an updated understanding of the human papillomavirus natural history. While the previous human papillomavirus natural history model considered human papillomavirus detection to be a result of human papillomavirus acquisition or possibly reinfection, and loss of human papillomavirus detection to be a result of viral clearance, the updated understanding of the human papillomavirus natural history is more nuanced. Thus, human papillomavirus detection may occur as a result of autoinoculation, deposition from a recent sex act, or as a redetection of a previously acquired infection. Similarly, loss of human papillomavirus detection likely reflects immune control rather than complete viral clearance. As it is practically impossible to identify the "true" source of a new human papillomavirus detection or determine why human papillomavirus is no longer detectable, we propose that healthcare providers and researchers use the terminology human papillomavirus detected vs human papillomavirus not detected. Moreover, we describe the updated understanding in a clinical context. Specifically, we discuss the potential implications of the updated understanding regarding clinical counseling in screening, recommendations on cervical screening, and human papillomavirus vaccination. We also suggest key phrases that healthcare providers may use when counseling women attending routine human papillomavirus-based cervical screening.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.